[Has interleukin 2 modified the outcome of metastatic renal cancer?].
Négrier
S
S
Philip
T
T
D003131:Combined Modality Therapy; D006801:Humans; D016219:Immunotherapy, Adoptive; D007262:Infusions, Intravenous; D016898:Interferon-alpha / Q000627:therapeutic use; D007376:Interleukin-2 / Q000008:administration & dosage / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000556:secondary / Q000628:therapy*
D016898:Interferon-alpha; D007376:Interleukin-2
L'interleukine 2 a-t-elle modifié le devenir du cancer du rein métastatique?